These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37587056)

  • 21. Low-dose corticosteroid therapy improves refractory coronary vasospasm accompanied by eosinophilic granulomatosis with polyangiitis.
    Watanabe K; Yamochi W; Oshitani T; Taniguchi H
    J Cardiol Cases; 2021 Feb; 23(2):69-72. PubMed ID: 33520026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Uematsu H; Takata S; Sueishi K; Inoue H
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
    Steinfeld J; Bradford ES; Brown J; Mallett S; Yancey SW; Akuthota P; Cid MC; Gleich GJ; Jayne D; Khoury P; Langford CA; Merkel PA; Moosig F; Specks U; Weller PF; Wechsler ME
    J Allergy Clin Immunol; 2019 Jun; 143(6):2170-2177. PubMed ID: 30578883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis.
    Higashitani K; Yoshimi R; Sato Y; Watanabe T; Ihata A
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):87-92. PubMed ID: 34473835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis.
    Ríos-Garcés R; Prieto-González S; Hernández-Rodríguez J; Arismendi E; Alobid I; Penatti AE; Cid MC; Espígol-Frigolé G
    Eur J Intern Med; 2022 Jan; 95():61-66. PubMed ID: 34535374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases.
    Fargeas M; Devouassoux G; Gerfaud-Valentin M
    Respir Med Res; 2024 Jun; 85():101070. PubMed ID: 38141578
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis.
    Belfeki N; Abroug S; Ghriss N; Chouchane I; Hamrouni S; Strazzulla A; Zayet S
    Clin Exp Rheumatol; 2021 Oct; 40(4):834-837. PubMed ID: 35522541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother.
    Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N
    Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Eosinophilic granulomatosis with polyangiitis presenting with ischemic optic neuropathy].
    Imanaka S; Komatsu K; Oka Y; Takahashi M
    Rinsho Shinkeigaku; 2022 Jun; 62(6):481-486. PubMed ID: 35644584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful early introduction of mepolizumab for peripheral neuropathy with a peripheral circulatory disorder in a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
    Nishihara M; Hamaguchi M; Ikumi N; Nishiwaki A; Sugiyama K; Nagasawa Y; Tsuzuki H; Yoshizawa S; Tanikawa Y; Asatani S; Kobayashi H; Takei M; Kitamura N
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):354-359. PubMed ID: 33970058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and Disease Burden of Patients With Eosinophilic Granulomatosis With Polyangiitis Initiating Mepolizumab in the United States.
    Silver J; Deb A; Packnett E; McMorrow D; Morrow C; Bogart M
    J Clin Rheumatol; 2023 Dec; 29(8):381-387. PubMed ID: 37779234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal Involvement as Rare Acute Tubulointerstitial Nephritis in a Patient with Eosinophilic Disorder Treated with Early Add-on Administration of Mepolizumab.
    Hayama Y; Tomyo F; Ueno M; Asakawa S; Arai S; Yamazaki O; Tamura Y; Mochizuki M; Ohashi R; Shibata S; Fujigaki Y
    Intern Med; 2021 Dec; 60(23):3759-3764. PubMed ID: 34092738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
    Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Case report of effective intravenous immunoglobulin for lower limbs pain in steroid-resistant eosinophilic granulomatosis with polyangiitis].
    Tsuchida M; Fukushima T; Makino K; Miida H; Kuwabara T
    Rinsho Shinkeigaku; 2014; 54(3):231-3. PubMed ID: 24705839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac tamponade leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature.
    Yano T; Ishimura S; Furukawa T; Koyama M; Tanaka M; Shimoshige S; Hashimoto A; Miura T
    Heart Vessels; 2015 Nov; 30(6):841-4. PubMed ID: 25070496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilic granulomatosis with polyangiitis as a rare cause of the syndrome of inappropriate antidiuretic hormone secretion.
    Dellal FD; Karaahmetli G; Guven SC; Aydin C; Topaloglu O; Ersoy R; Cakir B
    Ir J Med Sci; 2023 Jun; 192(3):1171-1176. PubMed ID: 35895178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mepolizumab as a glucocorticoid-sparing agent in eosinophilic granulomatosis with polyangiitis (EGPA): is a lower dose sufficient?
    Vergles M; Matković Z; Lalić K; Trkanjec JT; Tudorić N
    J Asthma; 2021 Dec; 58(12):1675-1679. PubMed ID: 32962455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].
    Carrette A; Mercier V; Lelubre C; Peché R
    Rev Mal Respir; 2022 Sep; 39(7):621-625. PubMed ID: 35909008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
    Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S
    Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.